Home Industry Reports Custom Research Blogs About Us Contact us

U.S. Next-generation Sequencing Services Market

Report ID: FBI 3852

|

Published Date: Jun-2024

|

Format : PDF, Excel

Market Outlook:

The U.S. next-generation sequencing services market is expected to experience steady growth in the coming years due to a rising demand for personalized medicine and advancements in genomic research. Next-generation sequencing (NGS) has revolutionized the field of genomics by enabling rapid and cost-effective sequencing of DNA and RNA. This technology is widely used in various applications such as oncology, infectious diseases, genetic disorders, and agricultural research.

Next-generation Sequencing Services Market

Largest Region

North America

45% Market Share in 2023

Get more details on this report -

Market Dynamics:

Growth Drivers:

1. Rising prevalence of chronic diseases: The increasing incidence of cancer, cardiovascular diseases, and genetic disorders is fueling the demand for NGS services for early disease detection and personalized treatment plans.

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
2. Technological advancements: Continuous innovation in NGS technologies, such as increased sequencing speed and accuracy, is driving market growth.

3. Government initiatives: Initiatives by the U.S. government to promote precision medicine and genomic research are boosting the adoption of NGS services.

4. Growing research and development activities: Increased funding for genomics research and collaborations between academic institutions and biotech companies are driving market growth.

Industry Restraints:

1. High costs of NGS services: The high initial costs of NGS equipment and services may hinder market growth, especially for smaller research labs and academic institutions.

2. Data management and analysis challenges: Handling and interpreting the massive amount of data generated by NGS can be a challenge, requiring trained bioinformaticians and robust data management systems.

3. Regulatory hurdles: Stringent regulations related to data privacy and genetic testing may pose challenges for NGS service providers.

Segment Analysis:

The U.S. NGS services market can be segmented based on service type, end-user, and application. Service types include sequencing services, data analysis and interpretation, and other related services. End-users of NGS services include academic and research institutions, pharmaceutical companies, biotechnology firms, and hospitals and clinics. Applications of NGS services encompass oncology, infectious diseases, genetic disorders, agricultural research, and others.

Competitive Landscape:

The U.S. NGS services market is highly competitive, with key players such as Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Eurofins Scientific, and PerkinElmer, Inc. dominating the market. These companies are investing in research and development activities to enhance their product offerings and expand their customer base. Strategic collaborations, mergers and acquisitions, and product launches are commonly seen among market players to gain a competitive edge. As the demand for personalized medicine and genomic research continues to grow, the U.S. NGS services market is expected to witness intense competition and innovation in the coming years.

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Next-generation Sequencing Services Market Size & ...

RD Code : 24